SHIELD THERAPEUTICS ORD 1.5P
SHIELD THERAPEUTICS ORD 1.5P
- GBX (-)
- 15 min delayed data - London Stock Exchange
Open: -
Change: -
Volume: -
Low: -
High: -
High / Low range: -
Type: Stocks
Ticker: STX
ISIN: GB00BYV81293

Executive interview – Shield Therapeutics

  • 92
Shield Therapeutics is a commercial-stage speciality pharmaceutical company based in the United Kingdom that listed on AIM in 2016. Its primary focus is the ...
Edison
Edison
Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations, ESG and strategic consulting. All interviews have been prepared and issued by Edison for publication globally. View our full disclaimer - http://www.edisoninvestmentresearch.com/disclaimer/client-email-disclaimer Edison is authorised and regulated by the Financial Conduct Authority (www.fsa.gov.uk/register/firmBasicDetails.do?sid=181584